iZafe Group

iZafe Group OCF Margin

The Operating Cash Flow Margin of iZafe Group (IZAFE B.ST) as of Nov 17, 2026 is -243.00 %. In the previous year, Operating Cash Flow Margin was -142.76 % — a change of 70.22% (lower).

OCF Margin

-243.00 %

YoY

70.22%

Last updated:

Operating Cash Flow Margin of iZafe Group is 2025 -243.00 % . Operating Cash Flow Margin of iZafe Group was 2024 -142.76 % . It decreases by 70.22% lower compared to the previous year.

The iZafe Group OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2018
-18.62 SEK
Jan 1, 2019
-106.92 SEK
Jan 1, 2020
-275.91 SEK
Jan 1, 2021
-7,577.60 SEK
Jan 1, 2022
-2,943.35 SEK
Jan 1, 2023
-617.78 SEK
Jan 1, 2024
-142.76 SEK
Jan 1, 2025
-243.00 SEK
The iZafe Group OCF Margin history
YEAROCF MarginYoY
-243.00 %+70.22%
-142.76 %-76.89%
-617.78 %-79.01%
-2,943.35 %-61.16%
-7,577.60 %+2,646.41%
-275.91 %+158.06%
-106.92 %+474.09%
-18.62 %-99.22%
-2,399.35 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

iZafe Group Stock analysis

What does iZafe Group do? iZafe Group AB develops medical and digital security solutions, including Dosell, a patented drug dispenser for home medication with remote monitoring, and MediKoll, an app providing medication side effect and allergy information. The company serves pharmaceutical companies, hospitals, care homes, and pharmacies in the global market. Its products target patients and healthcare providers seeking secure, remote medication management and personalized health information. Dosell is under development as a home medication solution, while MediKoll offers real-time data on medication reactions. The firm's revenue comes from selling these digital tools to healthcare institutions and pharmaceutical partners, focusing on improving patient safety and reducing medication errors through technology. iZafe Group AB's business model relies on the global healthcare sector's demand for innovative digital tools. The company's offerings are tailored for pharmaceutical firms, hospitals, care homes, and pharmacies, leveraging remote monitoring capabilities to address medication management challenges in home and clinical settings. iZafe Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about iZafe Group stock

Operating Cash Flow Margin of iZafe Group is -243.00 % in 2025.

Operating Cash Flow Margin of iZafe Group changed from -142.76 % to -243.00 %, representing a 70.22% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin iZafe Group since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's iZafe Group with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — iZafe Group

All Key Metrics — iZafe Group